Cristian Massacesi: Another memorable congress for AstraZeneca to present over 100 abstracts at ASCO 24

Cristian Massacesi, Chief Medical Officer and Oncology Chief Development Officer at AstraZeneca, posted on LinkedIn:

“ASCO is my favorite time of the year – and ASCO24 is set to be another memorable congress for AstraZeneca as we head to Chicago to present over 100 abstracts, including two special plenaries. These data reflect the work of our dedicated teams who are inspired by patients and are determined to achieve better outcomes across all types and stages of cancer. In particular, we’re excited to share data highlighting what can be achieved by diagnosing and treating patients early, where we believe there is the greatest potential for cure.

ASCO also provides a moment to connect with others and discuss how far we’ve come together in our mission to transform cancer treatment. With that in mind, I’m looking forward to joining other leaders from pharma and academia for an Endpoints panel discussion on June 4 to share perspectives on the research presented.
For those of you planning to be there, see you in Chicago!”

Source: Cristian Massacesi/LinkedIn
.